Innovus Pharma Secures $0.5M Commitment From Its Chief Executive Officer

Published: Mar 20, 2013

LA JOLLA, Calif., March 20, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCBB:INNV) today announced that it received a $0.5M funding commitment from its President and Chief Executive Officer, Dr. Bassam Damaj. In connection with this commitment, the Company's independent registered public accounting firm has issued its audit opinion on the Company's 2012 and 2011 financial statements free of a "going concern" qualification.

Back to news